Psoriasis is an incurable skin disease that develops in about two-thirds of patients before the
age of 40 and requires lifelong treatment; its pathological mechanisms have not been fully …

Psoriasis is a common inflammatory skin disease characterized by abnormal proliferation of
epidermal keratinocytes and massive infiltration of inflammatory cells. Many kinds of cells …

Psoriasis is a chronic inflammatory skin disorder, and current treatments include topical
therapies, phototherapy, systemic immune modulators, and biologics, aiming to alleviate …

Psoriasis is a chronic immune-mediated disease that is linked to an increased risk of cancer.
Although numerous studies have explored whether neoplasms are concurrent conditions or …

Psoriasis is a common, chronic, and inflammatory skin disease with a high burden on
individuals, health systems, and society worldwide. With the immunological pathologies and …

Psoriasis is a chronic inflammatory skin disease characterized by IL-17-dominant abnormal
innate and acquired immunity, and the hyperproliferation and aberrant differentiation of …

Background: Psoriasis is a challenging skin disorder due to its chronicity, high rate of
prevalence, disability, comorbidity and disfiguration. It is a multi-system disorder that …

Psoriasis is a common inflammatory skin disease involving interactions between
keratinocytes and immune cells that significantly affects the quality of life. It is characterized …

Psoriasis is a complex long-lasting inflammatory skin disease with high prevalence and
associated comorbidity. It is characterized by epidermal hyperplasia and dermal infiltration …

Psoriasis is a chronic inflammatory skin disease characterised by elevated red scaly
plaques on specific body sites. Histologically, the plaques are defined by epidermal …